Home
Pharmatek

Pharmatek Market Share Analysis for November 2025

Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.

Health > Biotechnology and Pharmaceuticals

Domainpharmatek.com

Year Founded1999

Employees51 - 200

Annual Revenue$25M - $50M

Pharmatek

Pharmatek (including company regionals)

pharmatek.com

See more website traffic and engagement information

Pharmatek Revenue up to November 2025 is 25M - 50M

revenue generated by Pharmatek top domains

Pharmatek top domains revenue over 3 years

Revenue for Pharmatek top domains

pharmatek.com25M - 50M

See more with Sales Intelligence

Total visits to Pharmatek's top domains

Understand Pharmatek market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pharmatek's top domains

Analyze Pharmatek engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pharmatek's top domains

See how Pharmatek keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pharmatek top competitors by domain

Top similar sites in November 2025, ranked by their affinity

corerxpharma.comCompany NameCoreRx, Inc.,Employees201 - 500HQUnited States, Florida, ClearwaterAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Pharmatek

These are the website technologies, by industry, used by Pharmatek top domains

Social (3)

Instagram

Widget (3)

Twemoji

Advertising (2)

Twitter Advertiser

Audio Video Media (2)

Vimeo

More Technologies

7

See all

News & Signals from Pharmatek

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCatalent Pharma Solutions acquired Pharmatek on Jan 1st '16.Catalent acquired Pharmatek in 2016 at which time Outsourcing-Pharma.com reported the addition would expand Catalent’s bioavailability enhancement offering.